Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan-Dec:12:23247096241253343.
doi: 10.1177/23247096241253343.

Concomitantly Diagnosed Disseminated M kansasii Infection and Hairy Cell Leukemia With Review of Pathophysiology

Affiliations
Review

Concomitantly Diagnosed Disseminated M kansasii Infection and Hairy Cell Leukemia With Review of Pathophysiology

Daniel J Stanton et al. J Investig Med High Impact Case Rep. 2024 Jan-Dec.

Abstract

The association between Hairy Cell Leukemia (HCL) and non-tuberculous mycobacterial infections (NTMs) is well described, most notably Mycobacterium kansasii. The exact pathophysiology is not known. We report a case of a 31-year-old male with concomitantly diagnosed HCL and disseminated M kansasii infection who presented with rash, pancytopenia, and bulky axillary lymphadenopathy. The M kansasii was initially diagnosed through use of cell-free DNA detection and confirmed by bone marrow and lymph node cultures. Hairy Cell Leukemia was diagnosed with peripheral flow cytometry and confirmed via the same bone marrow sample. His HCL was put into remission with a single course of cladribine and rituximab chemotherapy; however, his M kansasii infection persisted for 6 months despite aggressive antimicrobial and surgical therapy. It was finally controlled using high-dose rifampin in combination with azithromycin and ethambutol. This case highlights the known link between HCL and M kansasii. Furthermore, it hints at potential causes beyond chemotherapy-induced immunocompromise. Notable possibilities include HCL cells acting as sanctuary sites for M kansasii to evade the immune system, and subclinical M kansasii infections causing NLRP3 inflammasome overactivation to trigger the oncogenic transformation to HCL. More research into the pathophysiologic link between HCL and M kansasii infections would allow for more effective prevention, diagnosis, and treatment of these severe atypical infections which are the major cause of morbidity in the cladribine era of HCL treatment.

Keywords: Hairy Cell Leukemia; Mycobacterium kansasii; immunocompromise; non-tuberculous mycobacterium; pathophysiology.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Image of patient’s rash.
Figure 2.
Figure 2.
Computed tomography with contrast of patient’s thorax showing bulky lymphadenopathy in right axilla.

References

    1. Johnston JC, Chiang L, Elwood K. Mycobacterium kansasii. Microbiol Spectr. 2017;5. doi:10.1128/microbiolspec.tnmi7-0011-2016 - DOI - PMC - PubMed
    1. Jagielski T, Borówka P, Bakuła Z, et al.. Genomic insights into the Mycobacterium kansasii complex: an update. Front Microbiol. 2020;10:2918. doi:10.3389/fmicb.2019.02918 - DOI - PMC - PubMed
    1. Bennett C, Vardiman J, Golomb H. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986;80(5):891-896. - PubMed
    1. Ramasamy C, Dubashi B, Sree Rekha J, Basu D, Jain A, Dutta TK. Atypical mycobacterial infection in hairy cell leukemia treated with cladribine. Indian J Hematol Blood Transfus. 2014;30(1):59-61. - PMC - PubMed
    1. Kramers C, Raemaekers JMM, Van Baar HMJ, et al.. Sweet’s syndrome as the presenting symptom of hairy cell leukemia with concomitant infection by Mycobacterium kansasii. Ann Hematol. 1992;65(1):55-58. - PubMed

MeSH terms